Get Started

LGVN

NASD Longeveron Inc. Class A
Oct 31, 2026 · 10:43 AM ET EOD Market Closed

$1.67 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.67, $0.13 below the day’s high of $1.80

YTD change
-67.00%
vs 20-day SMA
-12.85%
vs 200-day SMA
-74.91%

Price ranges

Previous day
$1.58 $1.80
open $1.78 close $1.67
-$0.11 (-6.18%)
Today
$1.58 $1.80
$1.67
Past week
$1.48 $1.86
from $1.59 now $1.67
+$0.08 (+5.03%)
Past month
$1.31 $2.69
from $2.59 now $1.67
-$0.92 (-35.52%)
This year
$0.48 $7.60
from $5.06 now $1.67
-$3.39 (-67.00%)

Price & Performance

+0.82 (+96.24%) / 6M

$0.0562$2.66$5.26$7.87May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $4,500.00
  • LGVN is down 67% since the beginning of the year
  • LGVN is down 80% over the past 12 months
  • LGVN is down 36% over the past 1 month
  • 4% of all LGVN investors are betting against LGVN

LGVN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +100.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.9
Earnings momentum -11.8% Quarterly EPS growth
Quarterly change -11.8%

Valuation

P/E ratio N/A
Enterprise value $-4004910.0
Beta -1.35

Balance sheet & scale

IncomeN/A
Revenue$1.2M
Cash$10.1M
Debt$581.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $5.1M

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.